MedCity News
@medcitynews.com did:plc:6gthyik6r6c4funxw5imwqkz
MedCity News is a trusted source for healthcare innovation news and analysis for busy professionals and senior executives. Sign up for our newsletters: https://medcitynews.com/subscribe/
Bei Bluesky seit
- Follower
- 320
- Folgt
- 688
- Posts
- 2.321
- Tage in Ranglisten
- 0
Zusammenfassung
MedCity News (@medcitynews.com) ist seit 19 November 2024 auf Bluesky. Das Konto hat 320 Follower, folgt 688 Konten und hat 2.321 Posts veröffentlicht.
Ranglisten-Platzierungen
Die besten Tage, an denen Posts dieses Kontos in Debyas Tagesliste kamen.
Dieses Konto war noch in keiner Tagesrangliste.
Zuletzt gelikte Posts
Öffentliche Likes aus dem Bluesky-Netzwerk.
#FDA proposes ending testing for biosimilars, which are lower-cost versions of complex biologic medicines. buff.ly/JYiRNe1 via @medcitynews.com #clinicaltrials #clinicalresearch
Post anzeigen@medcitynews.bsky.social interviewed Synapticure CEO, co-founder, and caregiver Sandra Abrevaya on our plans to revolutionize neurodegenerative care & treatment nationwide. Read how Synapticure is leading the new era of care: medcitynews.com/2024/11/syna... #SeriesA #VirtualCare #Alzheimers
Post anzeigenMany great behavioral health #healthequity perspectives in this article by Marissa Plescia of @medcitynews.com: medcitynews.com/2024/11/trus...
Post anzeigenRead and share this op-ed from the awesome Desiree Lindsay on her SIXTEEN YEAR personal struggle to diagnosis. Listen to #PatientVoices. (via @medcitynews.com) #WomensHealth medcitynews.com/2024/12/endo...
Post anzeigenDr. Eric Topol: Generative AI Studies Boast Promising Results, But Real-World Challenges Remain @medcitynews.com with @erictopol.bsky.social medcitynews.com/2024/12/gene...
Post anzeigen
Blockierte Konten
Blockierungen sind auf Bluesky öffentlich.
Dieses Konto blockiert niemanden.